Provided by Tiger Trade Technology Pte. Ltd.

JPMORGAN HEALTHCARE LEADERS ETF

64.43
+0.25810.40%
Volume:226
Turnover:14.56K
Market Cap:9.66M
PE:- -
High:64.43
Open:64.43
Low:64.43
Close:64.17
52wk High:64.56
52wk Low:50.34
Shares:150.00K
Float Shares:150.00K
Volume Ratio:2.92
T/O Rate:0.15%
Dividend:0.51
Dividend Rate:0.80%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Merck up over 9%, on Track for Record High Close

Dow Jones
·
Aug 19

Merck & Co Inc Stock (MRK) Opened Up by 8.82% on Aug 19: Key Drivers Unveiled

TradingKey
·
Aug 19

Merck, Amgen Share Gains Contribute to Dow's 161-Point Climb

Dow Jones
·
Aug 19

Moderna Stock Price Doubles on Melanoma Vaccine News

Dow Jones
·
Aug 19

Merck Shares Touch Record High, Last up 9.6%

THOMSON REUTERS
·
Aug 19

Shares of Moderna Rise 87%, Merck Rise 6.8% After Skin Cancer Vaccine Succeeds in Late-Stage Trial

THOMSON REUTERS
·
Aug 19

Sector Update: Healthcare

MT Newswires Live
·
Aug 19

Biotech Stocks Jump Premarket After Moderna's Melanoma Vaccine with Merck Succeeds in Large Trial

THOMSON REUTERS
·
Aug 19

The Bond Selloff is Rattling Investors, but Here's Why They Shouldn't Expect a Deeper Stock Downturn

Dow Jones
·
Aug 19

Stocks to Watch: Oracle, SK Hynix, Moderna, Unitree

Dow Jones
·
Aug 19

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Dow Jones
·
Aug 19

U.S. Stocks on the MOVE-Estee Lauder, Target, Analog Devices

Reuters
·
Aug 19

Merck, Moderna Say Potential Melanoma Therapy Shows 'Statistically Significant Improvement' in Late-Stage Trial

MT Newswires Live
·
Aug 19

Bond Yields, Persian Gulf Outlooks Cap Wall Street Pre-Bell; Asia, Europe Off

MT Newswires Live
·
Aug 19

Moderna Stock Surges 70%, Merck Rises 6%. at Last, a Successful Cancer Vaccine.

Dow Jones
·
Aug 19

Moderna and Merck Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Moderna Vaccine Cuts Recurrence and Spread of High-Risk Melanoma, Raising New Treatment Hope

Reuters
·
Aug 19

Merck Shares Rise 1.9% Premarket

THOMSON REUTERS
·
Aug 19

Merck, Moderna Say Melanoma Skin Cancer Vaccine Meets Goals in Large Trial

Reuters
·
Aug 19

Merck: Safety Profiles of Intismeran and Keytruda in Trial were Consistent with Prior Reported Studies for the Combination

THOMSON REUTERS
·
Aug 19